Loading clinical trials...
Loading clinical trials...
A Randomized Phase II Evaluation of Continuous Progestin Therapy vs. Sequential Progestin Therapy in the Treatment of Endometrial Intraepithelial Neoplasia (EIN) From a Referred Cohort of Atypical Endometrial Hyperplasia (AEH) or EIN Patients That Desire Uterine Preservation
Conditions
Interventions
Biopsy
Laboratory Biomarker Analysis
+4 more
Locations
50
United States
Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
Olive View-University of California Los Angeles Medical Center
Sylmar, California, United States
Hartford Hospital
Hartford, Connecticut, United States
Saint Francis Hospital and Medical Center
Hartford, Connecticut, United States
The Hospital of Central Connecticut
New Britain, Connecticut, United States
Memorial University Medical Center
Savannah, Georgia, United States
Start Date
July 1, 2007
Primary Completion Date
July 1, 2012
Last Updated
November 3, 2020
Lead Sponsor
Gynecologic Oncology Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions